価格表

在庫・価格 : 2024年05月02日 20時46分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-SDCBP, Mouse-Mono(2C12)
データシート※最新のデータシートでない場合があります
H00006386-M01 ABNアブノヴァ
Abnova Corporation
100 μg ¥72,000
(未発注)
追加

在庫・価格 : 2024年05月02日 20時46分 現在

Anti-SDCBP, Mouse-Mono(2C12)

  • 商品コード:H00006386-M01
  • メーカー:ABN
  • 包装:100μg
  • 価格: ¥72,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Yu Y et al. Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis. Mol Biosyst 2011 Jun;7(6):1908-16
Yu Y et al
2011/01/01
PubMed
2 Das SK et al. Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma. Cancer Res. 2012 Dec;72(23):6217-26
Das SK et al
2012/01/01
PubMed
3 Das SK et al. MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanoma. Cancer Res. 2013 Jan;73(2):844-54
Das SK et al
2013/01/01
PubMed
4 Dasgupta S et al. Novel role of MDA-9/syntenin in regulating urothelial cell proliferation by modulating EGFR signaling. Clin. Cancer Res. 2013 Sep;19(17):4621-33
Dasgupta S et al
2013/01/01
PubMed
5 Kim WY et al. Syntenin increases the invasiveness of small cell lung cancer cells by activating p38, AKT, focal adhesion kinase and SP1. Exp. Mol. Med. 2014;46:e90
Kim WY et al
2014/01/01
PubMed
6 Oyesanya RA et al. MDA-9/Syntenin regulates differentiation and angiogenesis programs in head and neck squamous cell carcinoma. Oncoscience 2014;1(11):725-37
Oyesanya RA et al
2014/01/01
PubMed
7 Kannan A et al. Genetic Mutation and Exosome Signature of Human Papilloma Virus Associated Oropharyngeal Cancer. Sci Rep 2017 Apr;7:46102
Kannan A et al
2017/01/01
PubMed
8 Poma P et al. NF-κB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers. OMICS 2017 Apr;21(4):225-231
Poma P et al
2017/01/01
PubMed
9 Pradhan AK et al. Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β. Proc Natl Acad Sci U S A 2021 05;118(21)
Pradhan AK et al
2021/01/01
PubMed
10 Bhoopathi P et al. Regulation of neuroblastoma migration, invasion, and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin. Oncogene 2019 10;38(41):6781-6793
Bhoopathi P et al
2019/01/01
PubMed
11 Moser-Katz T et al. PDZ Proteins SCRIB and DLG1 Regulate Myeloma Cell Surface CD86 Expression, Growth, and Survival. Mol Cancer Res 2022 Jul;20(7):1122-1136
Moser-Katz T et al
2022/01/01
PubMed
12 Kilinc S et al. Oncogene-regulated release of extracellular vesicles. Dev Cell 2021 Jul;56(13):1989-2006.e6
Kilinc S et al
2021/01/01
PubMed
  • No.: 1
  • 文献情報:
    Yu Y et al. Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis. Mol Biosyst 2011 Jun;7(6):1908-16
    Yu Y et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Das SK et al. Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma. Cancer Res. 2012 Dec;72(23):6217-26
    Das SK et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Das SK et al. MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanoma. Cancer Res. 2013 Jan;73(2):844-54
    Das SK et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Dasgupta S et al. Novel role of MDA-9/syntenin in regulating urothelial cell proliferation by modulating EGFR signaling. Clin. Cancer Res. 2013 Sep;19(17):4621-33
    Dasgupta S et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Kim WY et al. Syntenin increases the invasiveness of small cell lung cancer cells by activating p38, AKT, focal adhesion kinase and SP1. Exp. Mol. Med. 2014;46:e90
    Kim WY et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Oyesanya RA et al. MDA-9/Syntenin regulates differentiation and angiogenesis programs in head and neck squamous cell carcinoma. Oncoscience 2014;1(11):725-37
    Oyesanya RA et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Kannan A et al. Genetic Mutation and Exosome Signature of Human Papilloma Virus Associated Oropharyngeal Cancer. Sci Rep 2017 Apr;7:46102
    Kannan A et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Poma P et al. NF-κB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers. OMICS 2017 Apr;21(4):225-231
    Poma P et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Pradhan AK et al. Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β. Proc Natl Acad Sci U S A 2021 05;118(21)
    Pradhan AK et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Bhoopathi P et al. Regulation of neuroblastoma migration, invasion, and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin. Oncogene 2019 10;38(41):6781-6793
    Bhoopathi P et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Moser-Katz T et al. PDZ Proteins SCRIB and DLG1 Regulate Myeloma Cell Surface CD86 Expression, Growth, and Survival. Mol Cancer Res 2022 Jul;20(7):1122-1136
    Moser-Katz T et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Kilinc S et al. Oncogene-regulated release of extracellular vesicles. Dev Cell 2021 Jul;56(13):1989-2006.e6
    Kilinc S et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed